FDA IS ATTEMPTING TO LIMIT YOUR ACCESS TO MEDICATION
Dear Patient or Caregiver,
Please help us serve you. Lee Silsby will be prohibited from shipping medications to you if the Ohio Board of Pharmacy does not support the Food and Drug Administration’s (“FDA”) recently-published Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the States and the Food and Drug Administration (the “FDA MOU”).
What is the FDA MOU?
The FDA MOU is an agreement between the FDA and State Boards of Pharmacy, government agencies that regulate compounders, to collect and report certain information to the FDA on an ongoing basis. If the state Boards of Pharmacy do not agree to the FDA MOU requirements compounding pharmacies located in that state may be restricted from shipping out of state. This is particularly concerning for all patients who receive compounded medication from out-of-state pharmacies. The enforcement deadline for compounding pharmacies is October 26, 2021. To learn more about the FDA MOU click links below.
How can I help?
We need your voice of advocacy to be represented to the Ohio Board of Pharmacy. Lee Silsby Compounding Pharmacy proudly resides in Cleveland, Ohio, so it is the decision of this Ohio agency that will determine whether or not we can legally ship medications out of state, in our current practice. Please share how this change will impact your life? Click here to provide your personal testimony. You may select to maintain your privacy while providing a testimony on this important matter.
Thank you for supporting and choosing Lee Silsby Compounding Pharmacy. Our work is important because of you.
All the best,
The Lee Silsby Family